All but one Houston-area RediClinics have reopened following Harvey’s exit
HOUSTON — As of Saturday, RediClinic has reopened 21 of its 22 clinics in Houston and the surrounding area. The clinics are operating on a modified schedule from 9 a.m-6 p.m.
“Over the past several days, Houston witnessed the strength of its people – it’s remarkable how our community has come together to respond to the devastation Harvey inflicted on Houston and the surrounding area,” stated Danielle Barrera, RediClinic’s chief operating and marketing officer. “Our incredibly dedicated associates are no exception. We’re extremely proud of their commitment and grateful for the collective strength of our community.”
RediClinic’s Kingwood location is currently closed due to flooding. Patients in this area should visit the nearby Atascocita clinic until further notice. All Austin and San Antonio RediClinic locations are open.
The Rite Aid Foundation donated $100,000 to the American Red Cross to help the victims, families and communities affected by Hurricane Harvey. As a wholly owned subsidiary of the Rite Aid, RediClinic is proud to participate in relief efforts. Additionally, RediClinic is in discussions with local agencies to aid in Houston’s recovery from Hurricane Harvey and is also working to provide disaster relief support to RediClinic associates impacted by the storm.
“As a Houston-based company, we have experienced first-hand the depth of devastation Harvey has caused,” said Web Golinkin, CEO of RediClinic. “RediClinic is grateful to all in our community, including our clinicians. We’re ready to do whatever we can to help Houston heal, and we are committed to its full recovery.”
Gilead to acquire Kite Pharma
FOSTER CITY and SANTA MONICA, Calif. — In a deal estimated at roughly $11.9 billion, Gilead Sciences will be acquiring leading cell therapy company Kite Pharma for $180 per share, the companies announced last week. Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicaabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a decision date of Nov. 29.
“The acquisition of Kite establishes Gilead as a leader in cellular therapy and provides a foundation from which to drive continued innovation for people with advanced cancers,” Gilead president and CEO John Milligan said. “The field of cell therapy has advanced very quickly, to the point where the science and technology have opened a clear path toward a potential cure for patients. We are greatly impressed with the Kite team and what they have accomplished, and share their belief that cell therapy will be the cornerstone of treating cancer. Our similar cultures and histories of driving rapid innovation in order to bring more effective and safer products to as many patients as possible make this an excellent strategic fit.”
Kite’s research and development and commercialization operations will remain based in Santa Monica, Calif., and its manufacturing will remain in El Segundo, Calif., Gilead said.
“From the release of our pivotal data for axi-cel, to our potential approval by the FDA, this is a year of milestones. Each and every accomplishment is a reflection of the talent that is unique to Kite,” Kite chairman, president and CEO Arie Belldegrun said. “We are excited that Gilead, one of the most innovative companies in the industry, recognized this value and shares our passion for developing cutting-edge and potentially curative therapies for patients.”
Innovation introduces PharmASSIST Light-Way storage, retrieval system
JOHNSON CITY, N.Y. — Pharmacy automation company Innovation has a new offering for pharmacies. The company’s new PharmASSIST Light-Way solution is a tool for will-call management, prescription order collation and inventory management for retail central fill/mail order pharmacies.
Light-Way is made up of configurable cabinetry featuring multicolored light strips, with the option to add such security measures as lockable doors with biometric light strips. The intelligent pick-to-light technology uses the lights to assist pharmacy staff by showing where to place or pickup prescriptions, or where to stock medication.
“There continues to be a need for affordable and highly configurable tools that improve the quality of the prescription fulfillment process, especially in the areas of medication picking, order collation, inventory management, and sortation. Existing tools are targeted at high volume facilities, come at high costs, and only address specific operational flows,” said Tom Boyer, COO at Innovation. “Our Light-Way technology breaks through these barriers by providing a fully configurable, low cost, guided pick-and-place solution that’s scalable to any size pharmacy.”
Light-Way is integrated with Innovation’s PharmASSIST Symphony workflow and operations management program. It also can be integrated with third-part pharmacy management systems through a software development kit, the company said.